Abstract
Treatment with bovine surfactant (SF-RI 1) was shown to be efficacious in improving pulmonary function and in increasing survival rate without BPD in very premature infants. Surfactant therapy did not affect the risk of major complications of prematurity.
Publication types
-
Clinical Trial
-
Multicenter Study
-
Randomized Controlled Trial
MeSH terms
-
Birth Weight
-
Female
-
Follow-Up Studies
-
Gestational Age
-
Humans
-
Infant, Newborn
-
Male
-
Multicenter Studies as Topic
-
Pulmonary Surfactants / administration & dosage*
-
Randomized Controlled Trials as Topic
-
Respiratory Distress Syndrome, Newborn / prevention & control*